Treatments

COVID Smell Loss: 'Retraining' Mostly Flops in Trial Some patients did recover olfactory function with two-prong therapy, however Kate Kneisel medpagetoday

...

Bimodal olfactory training with visual cues and the use of patient-preferred scents did not produce a clinically meaningful improvement in sense of smell among individuals with COVID-19–related olfactory loss, a 275-patient randomized trial showed.

...

China's COVID cases overwhelm hospitals In more than three decades of emergency medicine, Beijing-based doctor Howard Bernstein said, he has never seen anything like this. Martin Quin Pollard Reuters

...

Uganda gets Ebola vaccine doses for trial on Sudan strain KAMPALA, Uganda (AP) — Uganda’s government says it has received more than 5,000 doses of Ebola vaccines for a clinical trial to assess their protection against the Sudan strain of the virus that caused an outbreak with over 50 deaths. AP NEWS

...

This outbreak, the first in a decade of the less common Sudan strain, is a chance for clinical trials of the three vaccines donated by the U.S.-based Sabin Vaccine Institute, University of Oxford and Merck.

Health Care — New CDC data backs up bivalent booster potency If you ever feel like your dog is judging, they just might be. New research found dogs can determine human aptitude, and they will look to people who they think are more competent.  Today… jbyrnes The Hill

...

New data from the Centers for Disease Control and Prevention (CDC) show the bivalent COVID-19 booster shot was effective at reducing the risk of hospitalization and emergency room visits by at least 50 percent.